Group 1 - Bluefin Technology's stock surged over 18% on January 9, closing at 38.02 CNY per share, with a trading volume of 8.93 billion CNY and a turnover rate of 4.85% [1] - Strong Brain Technology, a leading player in the brain-computer interface (BCI) sector, completed approximately 2 billion CNY in financing, marking it as the second-largest financing in the global BCI field after Neuralink [4] - Bluefin Technology is a strategic investor in Strong Brain Technology and has exclusively undertaken the mass production of its core hardware modules [4] Group 2 - The brain-computer interface industry is experiencing a high growth phase driven by technological breakthroughs, policy support, and expectations of robotic ecosystem collaboration, with a projected market size of approximately 12.4 billion USD by 2034 and a CAGR of 17% from 2025 to 2034 [5] - The recent expectations for mass production and technological breakthroughs from Neuralink are likely to benefit A-share companies related to the brain-computer interface sector [5]

Core Insights - Innovation Medical has seen a stock price increase of 10.00%, achieving a consecutive five-day trading limit up, with the latest price at 34.64 yuan and a total market capitalization of 15.286 billion yuan [1] - The market is speculating around Innovation Medical's focus on brain-machine interface technology, particularly in stroke rehabilitation and assistive devices, with products already launched [1] Industry Developments - The Ministry of Industry and Information Technology, along with six other departments, has issued implementation opinions to promote innovation in the brain-machine interface industry, setting phased development goals [1] - The National Healthcare Security Administration has established independent billing items for brain-machine interfaces in relevant guidelines, with pricing standards already implemented in regions like Hubei and Zhejiang [1] - The industry standard for medical devices using brain-machine interface technology will officially take effect on January 1, 2026, providing regulatory support for the industry's development [1] - Domestic companies are advancing technology research and clinical validation in the brain-machine interface field, with some products achieving significant progress and demonstrating collaborative industry effects [1]

Core Insights - The brain-computer interface (BCI) sector is experiencing a surge in investment and interest, particularly following the announcement from Neuralink about plans for large-scale production by 2026 [1][2] - Strong Brain Technology has successfully raised 2 billion yuan to accelerate the development of core technologies and product scaling in the BCI field [1] - The Chinese government has recognized BCIs as a key future industry, with significant funding allocated to support research and development [1] Investment Trends - Major venture capital firms such as Sequoia China, IDG, and Baidu Ventures are investing in various BCI companies, indicating a potential boom in financing for the sector in 2026 [2] - The investment landscape is shifting from primarily medical-focused investors to include those from technology and consumer sectors, highlighting the broader applications of BCIs [2] Non-Invasive BCI Developments - Non-invasive BCIs, led by Strong Brain Technology, are gaining traction with applications in various fields including healthcare and entertainment [2][4] - Despite previous challenges in the non-invasive BCI market, advancements in technology are leading to improved signal quality and broader applications [4][5] - The current focus is on developing smart prosthetics and other applications rather than pure brain control, utilizing muscle signals and AI algorithms for better accuracy [4] Invasive BCI Innovations - Invasive BCIs are facing stringent regulatory and safety challenges but are still attracting investment due to their high technical barriers and clinical value [6][7] - Companies like Borycon and Ladder Medical are making significant strides in clinical trials and product development, with Borycon's system showing promising results in patient rehabilitation [9][10][12] - The competitive landscape includes several players in Beijing and Shanghai, with a focus on developing comprehensive systems that integrate electrodes, algorithms, and neural chips [7][15] Future Outlook - 2026 is anticipated to be a pivotal year for the BCI industry, with advancements in technology and regulatory support paving the way for broader adoption [17][18] - The establishment of independent billing for BCI services by the National Medical Insurance Administration reflects a commitment to supporting the industry's growth [17]

Core Insights - The article discusses the release of "10 Surprises for 2026" by TBS and Bloomberg, continuing the legacy of Byron Wien, who was known for his contrarian market insights and predictions [1][2] Group 1: Predictions Overview - The predictions cover six key areas: autonomous driving, real estate, technology capital, monetary policy, trade policy, and cryptocurrency, each challenging market expectations [4] - Waymo's autonomous taxis are expected to expand into more U.S. cities by 2026, leading to discussions about banning human driving in urban centers [4] - New York City's rental policies are shifting towards taxing vacant properties, which is anticipated to slightly reduce rental prices amid housing supply challenges [5] - SpaceX's IPO is projected to significantly increase the valuation of Elon Musk's business empire, potentially making him the world's first trillionaire [6] Group 2: Monetary and Trade Policies - The Federal Reserve is expected to maintain its current interest rate policy in 2026, resisting calls from former President Trump for rate cuts, emphasizing a focus on long-term economic stability [8] - The U.S. Supreme Court is likely to uphold Trump's tariff measures, which are not expected to have a significant impact on inflation, alleviating concerns about tariffs driving up prices [9] Group 3: Cryptocurrency Insights - Bitcoin is projected to attempt to reach its historical high from October 2025 but is unlikely to succeed, with its volatility expected to decrease, enhancing its perception as a store of value [10] - Financial products linked to Bitcoin are set to be introduced, targeting the baby boomer generation, which may broaden the appeal of cryptocurrency investments [10] Group 4: Anticipation for Remaining Predictions - The remaining four predictions have yet to be disclosed, generating significant interest among global investors and policy researchers, highlighting the value of contrarian thinking in identifying overlooked risks and opportunities [11]

Core Viewpoint - Lens Technology (06613) experienced a 9.24% increase in stock price, reaching HKD 28.86, with a trading volume of HKD 323 million [6]. Group 1: Financing and Investment - Qiang Brain Technology, one of the "Six Little Dragons" of Hangzhou, has completed approximately RMB 2 billion (around HKD 2.6 billion) in financing, marking the second-largest financing record globally in the brain-computer interface sector, following Neuralink [6]. - The funds raised by Qiang Brain Technology will be used to accelerate the research and development of core technologies in brain-computer interfaces, achieve breakthroughs in extreme engineering, and scale up product production [6]. Group 2: Strategic Partnerships - Lens Technology is a strategic investor in Qiang Brain Technology and is exclusively responsible for the mass production of Qiang Brain's core hardware modules [6]. - In November 2025, Lens Technology plans to donate a large number of intelligent bionic limbs to the Hunan Provincial Disabled Persons' Federation, with all core modules sourced from Lens Technology's production line [6]. - The company has over 10 years of deep cooperation with major North American clients and serves as a primary core supplier [6].

Core Viewpoint - Lens Technology (300433) (06613) has seen its stock price increase by over 5%, currently trading at 28.08 HKD with a transaction volume of 1.58 billion HKD, following news of a significant financing round by Qiangnao Technology in the brain-computer interface sector [1] Group 1: Financing and Investment - Qiangnao Technology, part of the "Six Little Dragons of Hangzhou," has completed approximately 2 billion RMB in financing, marking the second-largest funding round globally in the brain-computer interface field, after Neuralink [1] - The funds raised by Qiangnao Technology will be used to accelerate core technology research and development, engineering breakthroughs, product scaling, and mass production [1] Group 2: Strategic Partnerships - Lens Technology has stated on its investor interaction platform that it is a strategic investor in Qiangnao Technology and is the exclusive manufacturer for Qiangnao's core hardware modules [1] - In November 2025, Lens Technology and Qiangnao Technology plan to donate a large number of intelligent bionic limbs to the Hunan Provincial Disabled Persons' Federation, with all core modules sourced from Lens Technology's production line [1] - The company has over 10 years of deep cooperation with major North American clients and is a primary core supplier for them, leveraging its mass production experience and precision manufacturing capabilities to actively seek further collaborations [1]

Core Viewpoint - Lens Technology (06613) has seen a stock increase of over 5%, currently up 6.28% at HKD 28.08, with a trading volume of HKD 158 million [1] Group 1: Financing and Investment - Qiangnao Technology, one of the "Six Little Dragons" in Hangzhou, has completed approximately RMB 2 billion in financing, marking the second-largest financing record globally in the brain-computer interface sector, following Neuralink [1] - The funds raised by Qiangnao Technology will be used to accelerate core technology research and development, extreme engineering breakthroughs, product scaling, and mass production [1] Group 2: Strategic Partnerships - Lens Technology has stated on its investor interaction platform that it is a strategic investor in Qiangnao Technology and is the exclusive provider for the mass production of Qiangnao's core hardware modules [1] - In November 2025, Lens Technology and Qiangnao Technology plan to donate a large number of intelligent bionic limbs to the Hunan Provincial Disabled Persons' Federation, with all core modules sourced from Lens Technology's production line [1] - The company has over 10 years of deep cooperation with major North American clients and is a primary core supplier for them, leveraging mass production experience and strong precision manufacturing capabilities to actively seek further collaborations [1]

将投中网设为"星标⭐"，第一时间收获最新推送 脑机接口行业史上的第二大融资纪录。 作者丨 蒲凡 来源丨 投中网 我们的手指是怎么动起来的？ 乍看上去，这是个很傻的问题。无论我们是想挖鼻孔、挠痒痒、薅白头发，还是开车、看报、读书写字，再复杂的手指动作，准备工作也只有一个：动 动脑子。但对于科学家们而言，"动手指"却堪称人类未解之谜，因为人类的双手其实是世界上最精巧的机器，手部的每一寸肌肉和关节都拥有极大的活 动范围和精准度，确保每次发力能以最佳方式分散，仅手掌一个区域就有17000个触觉感受器和游离神经末梢。 另一方面，我们脑海中一闪而过的"念头"却是一个极其抽象的概念。人们虽然知道大脑通过神经元产生的电信号和化学信号，将"动一动"的想法传递给 手指。但人类在产生想法的过程中，"活跃"的脑区是不固定的。感觉皮层、前额叶皮层、边缘系统都有可能是发出指令的起点。更重要的是，人们的主 观意识仅仅是大脑决策的其中一个参考因素。在无意识状态下，大脑会通过视觉、听觉、味觉、嗅觉、触觉不断收集信息，同样做出动一动的决策，比 如闻到炸臭豆腐就下意识捂鼻子。 那么两套异常紧密的系统是如何衔接上的？具体是哪些信号精准地控制了我们的 ...

Core Viewpoint - The company, Entropy Technology (301330.SZ), plans to launch a prototype for its brain-computer interface business by March 2026, with no sales revenue generated from brain-computer products to date [1]. Group 1 - The brain-computer interface business is expected to release a prototype in March 2026 [1]. - Currently, the brain-computer products have not generated any sales revenue [1]. - The company has advised investors to be aware of investment risks associated with this business [1].

Market Overview - The A-share market opened with the Shanghai Composite Index up by 0.09% at 4086.76 points, while the Shenzhen Component Index and the ChiNext Index opened down by 0.30% and 0.69% respectively [2][3] - The Hang Seng Index opened up by 0.47%, with the Hang Seng Tech Index rising by 0.38% [5][6] Sector Performance - Real estate and oil & gas sectors showed strong performance, while the commercial aerospace sector remained active [1] - The computing hardware supply chain experienced adjustments, with CPO and memory sectors leading the declines; semiconductor, lithium mining, and brain-computer interface sectors also saw significant drops [3] Notable Stocks - China Petroleum & Chemical Corporation (Sinopec) hit the daily limit up, following news of its merger approval with China National Aviation Fuel [3] - In the Hong Kong market, new listings such as MiniMax opened significantly higher, with a 42.67% increase, and the company reported a total fundraising amount of approximately HKD 4.818 billion [6][7] Economic Indicators - The People's Bank of China conducted a 7-day reverse repurchase operation of CNY 34 billion at an interest rate of 1.40% [7] - The RMB to USD central parity rate was reported at 7.0128, an increase of 69 basis points from the previous day's rate [8]